Author

H. M. Atkins

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 4 Research Focus:cancer & tumor microenvironment· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

A. Kabanov· 2 shared D. Hwang· 2 shared J. D. Ramsey· 2 shared A. C. Arnold· 1 shared C. Lim· 1 shared C. M. Perou· 1 shared c. perou· 1 shared D. T. Philip· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Kabanov

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology

D. T. Philip, N. M. Goins, N. J. Catanzaro, I. Misumi, J. K. Whitmire, H. M. Atkins, H. M. Lazear

This study shows that IFN-lambda reduces HSV skin disease severity by limiting neutrophil-driven inflammation, independent of viral load.

bioRxiv · Sep 11, 2023Immunology

Combination of Polymeric Micelle Formulation of TGFβ Receptor Inhibitors and Paclitaxel Produce Consistent Response Across Different Mouse Models of TNBC

N. Vinod, D. Hwang, S. C. Fussell, T. C. Owens, O. C. Tofade, S. Copling, J. D. Ramsey, P. D. Radler, H. M. Atkins, E. E. Livingston, J. A. Ezzel, M. Sokolsky, H. Yuan, c. perou, A. Kabanov

This study combines polymeric micelle-formulated TGFβ receptor inhibitors with Paclitaxel to show consistent anti-tumor effects across multiple TNBC mouse models.

bioRxiv · Jun 14, 2023 · PreprintCancer Biology

High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast Cancer

C. Lim, D. Hwang, M. Yazdimamaghani, H. M. Atkins, H. Hyun, Y. Shin, J. D. Ramsey, C. M. Perou, M. Sokolsky-Papkov, A. Kabanov

This study evaluates high-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple-negative breast cancer, showing improved therapeutic outcomes and immune response.

bioRxiv · Aug 12, 2022Cancer Biology

Disruption of the surfactant protein A receptor SP-R210L (CD245α/MYO18Aα) alters respiratory function and iron sequestration in alveolar macrophages of aged mice

E. Yau, T. M. Umstead, R. Abdulqadir, K. Fino, Z. Guan, S. Hu, S. Diangelo, K. Hassan, S. Bingaman, H. M. Atkins, T. K. Cooper, A. C. Arnold, E. S. Halstead, Z. C. Chroneos

This study shows that disrupting the SP-R210L isoform in aged mice impairs respiratory function and iron sequestration in alveolar macrophages, leading to chronic dysregulation and increased interstitial lung disease risk.

bioRxiv · Apr 14, 2021 · PreprintPhysiology